Seven Mile Advisory Bristol Myers Squibb CO Transaction History

Seven Mile Advisory

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $4,989 - $5,657	104 Added 2.18%	4,881 $265 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $50,758 - $60,568	1,047 Added 28.07%	4,777 $245 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1,678 - $1,877	29 Added 0.78%	3,730 $216 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $235,790 - $261,808	3,701 New	3,701 $237 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

Stay updated on Seven Mile Advisory with notifications on news.